Takeda Pharmaceuticals agreed to pay $13.6 million to settle allegations that it paid kickbacks to doctors to prescribe an ...

Pharmaceutical companies, generic manufacturers, and pharmacists should be more careful about changing how pills look.

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The Justice Department sent a letter to Yale School of Medicine on ...

A new Ebola outbreak has been confirmed in Congo’s remote Ituri province, with 246 suspected cases and 65 deaths recorded so ...

The Supreme Court on Thursday preserved women’s access to the abortion drug mifepristone, rejecting lower-court ...

Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout ...

This week's episode of “The Readout LOUD” is all about health politics, including Marty Makary's departure as FDA ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. A landmark new treatment for schizophrenia ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

The authors have each served as director of the Centers for Disease Control and Prevention. One misguided narrative is that the CDC should focus only on a “core mission” of combatting infectious ...

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...